England's Pharmacy First scheme handles 3.3 million consultations in a year

The Pharmacy First programme in England has seen a sharp rise in demand since its launch in early 2024. Between March 2025 and February 2026, pharmacists carried out over 3.3 million consultations for common conditions. The scheme aims to ease pressure on GPs and hospitals by expanding access to treatments. The programme allows pharmacists to diagnose and prescribe medicines for seven minor illnesses without needing a GP’s approval. These include sore throats, earache, sinusitis, impetigo, infected insect bites, shingles, and uncomplicated urinary tract infections in women. Beyond prescriptions, pharmacies also offer support for eye, ear, and mouth problems, as well as blood pressure checks and contraception services.

From autumn 2026, the scheme will cover five more conditions. The government has allocated £340 million to fund the expansion. Additionally, all newly trained pharmacists will qualify as independent prescribers from 2026, further boosting the programme’s reach. Community pharmacies are increasingly seen as a first point of contact for minor health issues. By handling more cases, they help reduce waiting times at GP surgeries and emergency departments.

The Pharmacy First scheme continues to grow, with more conditions and funding on the way. By training pharmacists to prescribe independently, the programme strengthens local healthcare access. The changes are set to make treatment for minor illnesses faster and more convenient for patients.